In a 28‑year‑old woman with a history of recurrent herpes simplex labialis who presents with two pea‑sized, soft, mobile lymph nodes behind the right ear and a similar node in the left upper neck, what is the most likely diagnosis and appropriate initial management?

Reactive Lymphadenopathy Secondary to Herpes Simplex Labialis

The most likely diagnosis is reactive cervical and postauricular lymphadenopathy secondary to active or recent herpes simplex labialis infection, and the appropriate initial management is reassurance with observation if the nodes are soft, mobile, and non-tender, while initiating or optimizing antiviral therapy for the underlying HSV-1 infection. 1

Clinical Diagnosis and Pathophysiology

• Pea-sized, soft, mobile lymph nodes in the postauricular and cervical regions are characteristic of benign reactive lymphadenopathy triggered by HSV-1 reactivation in the perioral distribution. 2

• HSV-1 labialis causes local viral replication that drains to regional lymph nodes (postauricular, submandibular, and anterior cervical chains), producing transient lymphoid hyperplasia. 2

• The bilateral distribution (right postauricular and left upper cervical) is consistent with drainage patterns from recurrent orolabial HSV infection rather than a unilateral process. 2

When Laboratory Confirmation Is Not Required

• In an immunocompetent 28-year-old with a documented history of recurrent herpes labialis and typical soft, mobile lymph nodes, routine laboratory testing or biopsy is unnecessary. 1

• Laboratory confirmation should be reserved for atypical presentations: nodes that are hard, fixed, rapidly enlarging (>2 cm), or persisting beyond 4–6 weeks without an identifiable infectious trigger. 1

Initial Management Strategy

Observation and Reassurance

• Reactive lymphadenopathy from HSV labialis typically resolves spontaneously within 2–4 weeks as the viral episode subsides; no specific intervention for the nodes themselves is required. 2

• Schedule follow-up in 4 weeks to confirm resolution; persistent or enlarging nodes warrant further evaluation (complete blood count, imaging, possible biopsy). 1

Antiviral Therapy for Active or Frequent HSV Labialis

• If the patient is currently experiencing an active cold sore outbreak, initiate valacyclovir 2 g orally twice daily (12 hours apart) on a single day to shorten episode duration and reduce viral shedding. 1

• Alternative single-day regimens include famciclovir 1500 mg as a single oral dose, which offers comparable efficacy with simplified dosing. 1

• Treatment must be started during the prodromal phase or within 24 hours of lesion onset to achieve maximal benefit, as peak viral titers occur in the first 24 hours. 1

Suppressive Therapy for Frequent Recurrences

• Patients with six or more cold sore episodes per year should be offered daily suppressive therapy, which reduces recurrence frequency by ≥75%. 1

• First-line suppressive options include:

  • Valacyclovir 500 mg once daily (can increase to 1000 mg once daily for very frequent recurrences) 1
  • Famciclovir 250 mg twice daily 1
  • Acyclovir 400 mg twice daily 1

• After 1 year of continuous suppression, consider a trial off therapy to reassess recurrence frequency, as outbreak frequency naturally decreases over time in many patients. 1

Preventive Counseling to Reduce Future Recurrences

• Ultraviolet light exposure is a well-documented trigger; recommend daily application of SPF ≥15 sunscreen or zinc oxide–based lip protection before sun exposure. 1

• Additional common triggers include fever, psychological stress, and menstruation; counsel the patient to identify and mitigate personal triggers. 1

• Provide a prescription for episodic antiviral therapy to keep on hand so treatment can be initiated immediately at the first prodromal symptom (tingling, burning). 1

Red Flags Requiring Further Evaluation

• Hard, fixed, or matted lymph nodes suggest malignancy or atypical infection (e.g., mycobacterial disease) rather than reactive HSV lymphadenopathy. 1

• Nodes >2 cm or persisting beyond 4–6 weeks warrant imaging (ultrasound or CT) and possible fine-needle aspiration or excisional biopsy. 1

• Constitutional symptoms (fever, night sweats, unintentional weight loss) or hepatosplenomegaly indicate systemic disease requiring comprehensive workup. 2

Common Pitfalls to Avoid

• Do not order unnecessary imaging or biopsy for typical soft, mobile, small (<1.5 cm) nodes in a patient with a clear infectious trigger and no alarm features. 1

• Do not delay antiviral therapy while waiting for lymph node resolution; treating the underlying HSV infection is the most effective way to hasten node regression. 1

• Do not rely on topical antivirals alone; they provide only modest benefit and are substantially less effective than oral therapy for both episodic treatment and prevention of recurrences. 1